pre-miRNA Information
pre-miRNA hsa-mir-3194   
Genomic Coordinates chr20: 51452905 - 51452977
Description Homo sapiens miR-3194 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-3194-5p
Sequence 10| GGCCAGCCACCAGGAGGGCUG |30
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1344875175 4 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol EMC7   
Synonyms C11orf3, C15orf24, HT022, ORF1-FL1
Description ER membrane protein complex subunit 7
Transcript NM_020154   
Expression
Putative miRNA Targets on EMC7
3'UTR of EMC7
(miRNA target sites are highlighted)
>EMC7|NM_020154|3'UTR
   1 TCAGGCCGTCCAGAGCTGGCATTTGCACAAACACGGCAACACTGGGTGGCATCCAAGTCTTGGAAAACCGTGTGAAGCAA
  81 CTACTATAAACTTGAGTCATCCCGACGTTGATCTCTTACAACTGTGTATGTTAACTTTTTAGCACATGTTTTGTACTTGG
 161 TACACGAGAAAACCCAGCTTTCATCTTTTGTCTGTATGAGGTCAATATTGATGTCACTGAATTAATTACAGTGTCCTATA
 241 GAAAATGCCATTAATAAATTATATGAACTACTATACATTATGTATATTAATTAAAACATCTTAATCCAGAAAAAAAAAAA
 321 AAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' guCGGGAGGACCACCGACCGg 5'
            ||| ||| |   |||||| 
Target 5' agGCCGTCCAGA--GCTGGCa 3'
3 - 21 130.00 -19.50
2
miRNA  3' gucgggaggaccACCGACCGg 5'
                      ||| |||| 
Target 5' acacggcaacacTGGGTGGCa 3'
31 - 51 113.00 -16.90
3
miRNA  3' guCGGGAG--GACCACCGACcgg 5'
            ||::||  ||  || |||   
Target 5' caGCTTTCATCTTTTGTCTGtat 3'
175 - 197 89.00 -10.12
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30190655 8 COSMIC
COSN21907173 35 COSMIC
COSN30516944 35 COSMIC
COSN30109572 36 COSMIC
COSN31593865 37 COSMIC
COSN30487985 62 COSMIC
COSN31518030 69 COSMIC
COSN28193943 70 COSMIC
COSN30448844 103 COSMIC
COSN30132515 106 COSMIC
COSN30162965 115 COSMIC
COSN31487811 182 COSMIC
COSN31591538 200 COSMIC
COSN31486094 219 COSMIC
COSN5859969 300 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1264212783 2 dbSNP
rs764800614 7 dbSNP
rs201960302 8 dbSNP
rs763640178 11 dbSNP
rs1224522380 14 dbSNP
rs189947179 15 dbSNP
rs1301610390 17 dbSNP
rs746866414 18 dbSNP
rs778532651 24 dbSNP
rs766720002 25 dbSNP
rs775268525 27 dbSNP
rs763244343 28 dbSNP
rs773419602 29 dbSNP
rs372289953 34 dbSNP
rs200013278 35 dbSNP
rs1207493525 36 dbSNP
rs768519905 38 dbSNP
rs761905243 39 dbSNP
rs776831428 40 dbSNP
rs1179604609 42 dbSNP
rs768897338 46 dbSNP
rs914527059 47 dbSNP
rs746939025 48 dbSNP
rs780152685 49 dbSNP
rs771832394 50 dbSNP
rs1226272656 54 dbSNP
rs1289084663 56 dbSNP
rs964461483 65 dbSNP
rs988679696 69 dbSNP
rs749087670 70 dbSNP
rs1382743970 83 dbSNP
rs1247314950 102 dbSNP
rs1351938527 103 dbSNP
rs1035489323 106 dbSNP
rs572998974 107 dbSNP
rs952966508 122 dbSNP
rs1025816227 129 dbSNP
rs554598808 138 dbSNP
rs143031568 143 dbSNP
rs1006675922 146 dbSNP
rs757144639 148 dbSNP
rs1185332909 153 dbSNP
rs1378329311 163 dbSNP
rs755834337 165 dbSNP
rs896023147 166 dbSNP
rs1166245678 177 dbSNP
rs1346625532 177 dbSNP
rs1036247723 180 dbSNP
rs1464199860 194 dbSNP
rs1301799560 195 dbSNP
rs575560716 196 dbSNP
rs745373032 200 dbSNP
rs879161155 203 dbSNP
rs1040954537 207 dbSNP
rs1007713048 208 dbSNP
rs548791107 208 dbSNP
rs1471580615 209 dbSNP
rs557390608 209 dbSNP
rs1239006553 210 dbSNP
rs1187921970 212 dbSNP
rs386782867 212 dbSNP
rs568905541 212 dbSNP
rs889557336 214 dbSNP
rs1208242449 215 dbSNP
rs185186630 224 dbSNP
rs753743349 231 dbSNP
rs1049487458 252 dbSNP
rs1437165629 268 dbSNP
rs1248315426 270 dbSNP
rs1203173807 271 dbSNP
rs1461824030 272 dbSNP
rs1205570301 277 dbSNP
rs1236303767 278 dbSNP
rs947073361 282 dbSNP
rs1177605219 284 dbSNP
rs1042765448 295 dbSNP
rs1275399951 295 dbSNP
rs11638774 309 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gucgggaggaccaccGACCGg 5'
                         ||| | 
Target 5' -----cuccaaacucCUGACc 3'
1 - 16
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000256545.4 | 3UTR | CUCCAAACUCCUGACCUCAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
72 hsa-miR-3194-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT443250 C9orf170 chromosome 9 open reading frame 170 2 2
MIRT443284 ZC3H12A zinc finger CCCH-type containing 12A 2 2
MIRT461518 EMC7 ER membrane protein complex subunit 7 2 2
MIRT466738 SYNJ2BP synaptojanin 2 binding protein 2 2
MIRT467651 SLC7A1 solute carrier family 7 member 1 2 2
MIRT472998 MRPS23 mitochondrial ribosomal protein S23 2 4
MIRT477911 DUSP2 dual specificity phosphatase 2 2 2
MIRT480853 BLCAP bladder cancer associated protein 2 2
MIRT482890 IAH1 isoamyl acetate-hydrolyzing esterase 1 homolog 2 4
MIRT487295 SLC38A9 solute carrier family 38 member 9 2 2
MIRT488494 SFMBT2 Scm like with four mbt domains 2 2 4
MIRT489060 STARD3 StAR related lipid transfer domain containing 3 2 2
MIRT491209 MLLT1 MLLT1, super elongation complex subunit 2 4
MIRT491479 APC2 APC2, WNT signaling pathway regulator 2 8
MIRT492558 PRX periaxin 2 6
MIRT495499 SLC39A2 solute carrier family 39 member 2 2 2
MIRT496578 ZNF280D zinc finger protein 280D 2 2
MIRT496840 KCNIP2 potassium voltage-gated channel interacting protein 2 2 2
MIRT497840 CHD1 chromodomain helicase DNA binding protein 1 2 2
MIRT499396 PLCG2 phospholipase C gamma 2 2 7
MIRT503237 C16orf74 chromosome 16 open reading frame 74 2 4
MIRT512345 ZNF665 zinc finger protein 665 2 4
MIRT512527 ATCAY ATCAY, caytaxin 2 4
MIRT513160 PPIB peptidylprolyl isomerase B 2 2
MIRT514493 STOML1 stomatin like 1 2 2
MIRT517164 SLC28A1 solute carrier family 28 member 1 2 2
MIRT520463 TRPV2 transient receptor potential cation channel subfamily V member 2 2 2
MIRT524151 DIP2A disco interacting protein 2 homolog A 2 2
MIRT530324 TNFRSF10D TNF receptor superfamily member 10d 2 2
MIRT533747 TMEM184B transmembrane protein 184B 2 2
MIRT534259 SLC12A7 solute carrier family 12 member 7 2 2
MIRT561273 ZDHHC18 zinc finger DHHC-type containing 18 2 2
MIRT569126 TMC5 transmembrane channel like 5 2 4
MIRT569937 RAB8A RAB8A, member RAS oncogene family 2 2
MIRT570073 VPS8 VPS8, CORVET complex subunit 2 2
MIRT570636 KLF13 Kruppel like factor 13 2 2
MIRT571026 CENPP centromere protein P 2 2
MIRT573838 ZWINT ZW10 interacting kinetochore protein 2 2
MIRT574899 Plcg2 phospholipase C, gamma 2 2 5
MIRT576070 Poteg POTE ankyrin domain family, member G 2 2
MIRT576753 Tmem127 transmembrane protein 127 2 2
MIRT611795 WNT9A Wnt family member 9A 2 2
MIRT616756 SVOP SV2 related protein 2 2
MIRT630965 NGDN neuroguidin 2 2
MIRT634555 LYVE1 lymphatic vessel endothelial hyaluronan receptor 1 2 2
MIRT638646 GK5 glycerol kinase 5 (putative) 2 2
MIRT639903 SRGAP2 SLIT-ROBO Rho GTPase activating protein 2 2 2
MIRT640529 TET3 tet methylcytosine dioxygenase 3 2 4
MIRT644529 TMEM134 transmembrane protein 134 2 2
MIRT644887 C2orf50 chromosome 2 open reading frame 50 2 2
MIRT647729 CXCR2 C-X-C motif chemokine receptor 2 2 2
MIRT648086 FAM192A family with sequence similarity 192 member A 2 2
MIRT650808 PGRMC1 progesterone receptor membrane component 1 2 2
MIRT660505 ARPC2 actin related protein 2/3 complex subunit 2 2 2
MIRT667193 NODAL nodal growth differentiation factor 2 2
MIRT685675 PSMB7 proteasome subunit beta 7 2 2
MIRT692710 MEAF6 MYST/Esa1 associated factor 6 2 2
MIRT693598 SLC39A1 solute carrier family 39 member 1 2 2
MIRT698059 TRIOBP TRIO and F-actin binding protein 2 2
MIRT698292 TMEM2 transmembrane protein 2 2 2
MIRT702353 KLHL26 kelch like family member 26 2 2
MIRT708623 NUDT18 nudix hydrolase 18 2 2
MIRT714289 KBTBD11 kelch repeat and BTB domain containing 11 2 2
MIRT714577 WDR41 WD repeat domain 41 2 2
MIRT716734 APOL6 apolipoprotein L6 2 2
MIRT718781 RAC3 Rac family small GTPase 3 2 2
MIRT720973 ZBTB43 zinc finger and BTB domain containing 43 2 2
MIRT720986 TOM1 target of myb1 membrane trafficking protein 2 2
MIRT721391 LDLRAD4 low density lipoprotein receptor class A domain containing 4 2 2
MIRT722905 COA4 cytochrome c oxidase assembly factor 4 homolog 2 2
MIRT723205 ZNRF1 zinc and ring finger 1 2 2
MIRT725431 HIVEP3 human immunodeficiency virus type I enhancer binding protein 3 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-3194 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-3194 Cisplatin 5460033 NSC119875 approved sensitive cell line (W1)
hsa-mir-3194 Doxorubicin 31703 NSC123127 approved sensitive cell line (W1)
hsa-mir-3194 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-3194-5p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (PANC-1)
hsa-miR-3194-5p Fluorouracil 3385 NSC19893 approved sensitive High Pancreatic Cancer cell line (PANC-1)
hsa-miR-3194-5p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-3194-5p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-3194-5p Cisplatin 5460033 NSC119875 approved resistant Low Hepatocellular Carcinoma cell line (HepG2)
hsa-miR-3194-5p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (A172)
hsa-miR-3194-5p Estradiol 5757 NSC9895 approved sensitive Low Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-3194-5p Gefitinib 123631 NSC715055 approved sensitive cell line (PC9)
hsa-miR-3194-5p Osimertinib 71496458 NSC779217 approved resistant cell line (HCC827)
hsa-miR-3194-5p Vemurafenib 42611257 NSC761431 approved resistant cell line (451Lu)
hsa-miR-3194-5p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-3194-5p Osimertinib 71496458 NSC779217 approved resistant cell line (H1975)
hsa-miR-3194-5p Platinum 23939 resistant tissue
hsa-miR-3194-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3194-5p Gemcitabine 60750 NSC613327 approved resistant cell line (PANC-1) (1500 ng/ml)
hsa-miR-3194-5p Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR4)
hsa-miR-3194-5p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-3194-5p Cisplatin 5460033 NSC119875 approved resistant cell line (MDAH-2774)
hsa-miR-3194-5p Cisplatin 5460033 NSC119875 approved resistant cell line (TOV-112D)
hsa-miR-3194-5p Cisplatin 5460033 NSC119875 approved resistant cell line (OVSAHO)

Error report submission